List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 66 studies with search of:   "Exemestane"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Randomized Phase III Study of Exemestane (Aromasin) for 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed by Exemestane
Condition: Breast Neoplasms
Interventions: Drug: exemestane (Aromasin);   Drug: tamoxifen + exemestane
2 Recruiting Amgen Protocol No. 20060362 - A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Tumors;   Metastatic Cancer
Interventions: Drug: AMG 479 or placebo administered with either exemestane or fulvestrant;   Drug: AMG 479 or placebo administered with either exemestane or fulvestrant;   Drug: AMG 479 or placebo administered with either exemestane or fulvestrant
3 Recruiting Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: CP-751,871 + exemestane;   Drug: exemestane
4 Not yet recruiting Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Exemestane + Dasatinib;   Drug: Exemestane + Placebo
5 Active, not recruiting Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: placebo;   Drug: Celecoxib;   Drug: Exemestane
6 Terminated Adjuvant Post-Tamoxifen Exemestane Trial
Condition: Breast Cancer
Intervention: Drug: exemestane
7 Active, not recruiting Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: exemestane;   Drug: tamoxifen
8 Active, not recruiting The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
Conditions: Locally Advanced Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Exemestane
9 Not yet recruiting Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
Condition: Advanced Breast Cancer
Interventions: Drug: Bosutinib;   Drug: Exemestane
10 Recruiting Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
Conditions: Breast Cancer;   Estrogen Receptor-Positive Breast Cancer;   Breast Cancer, Estrogen Receptor-Positive;   ER+ Breast Cancer
Interventions: Drug: SNDX-275;   Drug: exemestane
11 Recruiting Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Exemestane;   Drug: Fulvestrant
12 Recruiting Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Exemestane;   Drug: Celecoxib
13 Completed Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
Condition: Breast Neoplasms
Interventions: Drug: Celecoxib;   Drug: Exemestane
14 Completed A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: exemestane
15 Terminated Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Condition: Hormone-Receptor Positive Breast Cancer
Intervention: Drug: exemestane and pazopanib
16 Completed Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients
Condition: Breast Neoplasms
Intervention: Drug: exemestane (Aromasin®)
17 Recruiting Aromasin vs Arimidex Study As Initial Hormonal Therapy in Postmenopausal Women With Advanced/Recurrent Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: exemestane;   Drug: anastrozole
18 Recruiting Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Exemestane
19 Terminated Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women
Condition: Breast Neoplasms
Intervention: Drug: exemestane
20 Active, not recruiting Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
Condition: Breast Cancer
Interventions: Drug: Raloxifene followed by combination therapy;   Drug: Exemestane followed by combination therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services